Skip to main content
. Author manuscript; available in PMC: 2015 Jun 16.
Published in final edited form as: J Immunol. 2006 Sep 1;177(5):3045–3054. doi: 10.4049/jimmunol.177.5.3045

Table I.

Comparison of biologic and toxic activity of mCTs

Nasal Adjuvant cAMP Inductiona (pmol/mg protein) Y1-Cell Assayb (pg/ml) Heal Loop Testc (W:L ratio)
nCT 104.4 ± 2.3†† 0.06 ± 0.01†† (1)d 164.3 ± 4.0††
E112K/KDEV 5.3 ± 0.3** 125.0 ± 20.8** (1/2083) 47.7 ± 9.7**
E112K/KDGL 6.5 ± 0.2** 166.7 ± 9.7** (1/2778) 41.7 ± 3.4**
E112K 7.0 ± 1.0** 234.1 ± 44.3* (1/3902) 45.5 ± 0.4**
PBS 7.4 ± 0.5** 37.6 ± 4.4**
a

CHO cells (1.5 × 104 cells/well) were cultured in F-10 medium containing 1 % FCS with 100 ng/ml of each toxin for 18 h, and the cAMP induction was assessed using an enzyme immunoassay. Values represent the mean ± SEM of nine culture wells in each group. **, p < 0.01, when compared with nCT. ††, p < 0.01, when compared with mCT E112K.

b

Y-1 cells were cultured with F-12 medium containing 15% horse serum and 2.5% FCS and serial dilution of each toxin for 24 h. The enterotoxin concentration required to initiate rounding was determined. Values represent the mean ± SEM of of 12 culture wells in each group. *, p < 0.05; **, p < 0.01, compared with nCT. ††, p < 0.01, when compared with mCT E112K.

c

The ratio of the weight in milligrams to length in centimeters (W:L ratio) after injection of dmCTs into the loop. Each loop was injected with 0.1 ml of 1 /xg of dmCTs or nCT. The weight and length of each loop were measured after 3 h values. Values represent the mean ± SEM of six loops in each group. **, p < 0.01, when compared with nCT. ††, p < 0.01, when compared with mCT E112K.

d

The values in parenthesis is the ratio of the toxicity of dmCTs to the toxicity of nCT.

HHS Vulnerability Disclosure